Historical Valuation
Global Medical REIT Inc (GMRE) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.99 is considered Undervalued compared with the five-year average of 72.08. The fair price of Global Medical REIT Inc (GMRE) is between 39.01 to 69.62 according to relative valuation methord. Compared to the current price of 35.28 USD , Global Medical REIT Inc is Undervalued By 9.55%.
Relative Value
Fair Zone
39.01-69.62
Current Price：35.28
9.55%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Global Medical REIT Inc (GMRE) has a current Price-to-Book (P/B) ratio of 1.11. Compared to its 3-year average P/B ratio of 1.16 , the current P/B ratio is approximately -4.82% higher. Relative to its 5-year average P/B ratio of 1.35, the current P/B ratio is about -18.08% higher. Global Medical REIT Inc (GMRE) has a Forward Free Cash Flow (FCF) yield of approximately 15.96%. Compared to its 3-year average FCF yield of 12.49%, the current FCF yield is approximately 27.71% lower. Relative to its 5-year average FCF yield of 10.43% , the current FCF yield is about 53.03% lower.
P/B
Median3y
1.16
Median5y
1.35
FCF Yield
Median3y
12.49
Median5y
10.43
Competitors Valuation Multiple
AI Analysis for GMRE
The average P/S ratio for GMRE competitors is 2.68, providing a benchmark for relative valuation. Global Medical REIT Inc Corp (GMRE.N) exhibits a P/S ratio of 2.99, which is 11.53% above the industry average. Given its robust revenue growth of 8.65%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for GMRE
1Y
3Y
5Y
Market capitalization of GMRE increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of GMRE in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is GMRE currently overvalued or undervalued?
Global Medical REIT Inc (GMRE) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.99 is considered Undervalued compared with the five-year average of 72.08. The fair price of Global Medical REIT Inc (GMRE) is between 39.01 to 69.62 according to relative valuation methord. Compared to the current price of 35.28 USD , Global Medical REIT Inc is Undervalued By 9.55% .
What is Global Medical REIT Inc (GMRE) fair value?
GMRE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Global Medical REIT Inc (GMRE) is between 39.01 to 69.62 according to relative valuation methord.
How does GMRE's valuation metrics compare to the industry average?
The average P/S ratio for GMRE's competitors is 2.68, providing a benchmark for relative valuation. Global Medical REIT Inc Corp (GMRE) exhibits a P/S ratio of 2.99, which is 11.53% above the industry average. Given its robust revenue growth of 8.65%, this premium appears unsustainable.
What is the current P/B ratio for Global Medical REIT Inc (GMRE) as of Jan 10 2026?
As of Jan 10 2026, Global Medical REIT Inc (GMRE) has a P/B ratio of 1.11. This indicates that the market values GMRE at 1.11 times its book value.
What is the current FCF Yield for Global Medical REIT Inc (GMRE) as of Jan 10 2026?
As of Jan 10 2026, Global Medical REIT Inc (GMRE) has a FCF Yield of 15.96%. This means that for every dollar of Global Medical REIT Inc’s market capitalization, the company generates 15.96 cents in free cash flow.
What is the current Forward P/E ratio for Global Medical REIT Inc (GMRE) as of Jan 10 2026?
As of Jan 10 2026, Global Medical REIT Inc (GMRE) has a Forward P/E ratio of 356.74. This means the market is willing to pay $356.74 for every dollar of Global Medical REIT Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Global Medical REIT Inc (GMRE) as of Jan 10 2026?
As of Jan 10 2026, Global Medical REIT Inc (GMRE) has a Forward P/S ratio of 2.99. This means the market is valuing GMRE at $2.99 for every dollar of expected revenue over the next 12 months.